journal article·2025-11-19

Mitochondria-Targeted HA-Coated Nanosystem for ROS/CO Generation and Metabolic Reprogramming to Enhance Tumoricidal Macrophage Polarization

Na Peng, Chun Song, Xiaoting Liu, Michał Nowicki, Roman Szewczyk, Yanyang Wang, Yi Liu

ACS Applied Materials & Interfaces· Volume 17· Issue 46
Publisher page

Abstract

Tumor-associated macrophage (TAM) polarization is related to mitochondrial function, stability, and ROS production. The development of a mitochondria-targeted nanosystem with immunomodulatory impact on TAM repolarization is crucial for macrophage-targeted immunotherapy. First, zirconium(IV) coordinated with tetra-kis(4-caboxyphenyl) porphyrin to synthesize PCN-224, which encapsulated CO-releasing molecule 401 (CORM-401) via the hollow structures (PCN-CORM), and then, an amphiphilic copolymer containing triphenylphosphine (TPP) was synthesized to load PCN-CORM via self-assembly and surface-coated with hyaluronic acid (HA) to obtain the mitochondria-targeted nanosystem (HA@MR@PCN-CORM). Mediated by HA and TPP motifs, HA@MR@PCN-CORM efficiently targeted mitochondria of TAMs via HA-CD44 interaction and re-exposed TPP groups by digesting HA and caused reactive oxygen species (ROS) and carbon dioxide (CO) storm under a laser irradiation of 660 nm (20 mW cm –2 ), and the killing rate of M2-like TAMs reached 66.8% at a PCN-224 concentration of 15 μg/mL. Moreover, HA@MR@PCN-CORM, through depletion of GSH, inhibition of glutamine metabolism, and metabolic reprogramming, resulted in an increased ratio of M1/M2-type TAMs from 0.29 to 1.20 and an in vivo tumor volume inhibition rate of 93.4% with synergistically enhanced infiltration of CD3 + /CD4 +, CD3 + /CD8 + T lymphocytes, and DCs in tumor tissues. The nanosystem was exhibited as a promising strategy for depletion and modulation of TAMs in an immunosuppressive tumor microenvironment for antitumor therapy.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Immune cells in cancer · Cancer, Hypoxia, and Metabolism

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Key Laboratory of Coal Conversion and New Carbon Materials of Hubei Province, School of Chemistry and Chemical Engineering

Wuhan University of Science and Technology

Chia-Poland Belt and Road Joint Laboratory on Measurement and Control Technology

Huazhong University of Science and Technology

Institute of Metrology and Biomedical Engineering Faculty of Mechatronics

Warsaw University of Technology

Department of Radiation Oncology

General Hospital of Ningxia Medical University

Institute of Medical Sciences

School of Chemistry and Materials Sciences & School of Pharmaceutical Sciences

South-Central Minzu University

Funding

Tianjin Municipal Science and Technology Bureau · Wuhan University of Science and Technology · National Natural Science Foundation of China · Belt and Road Joint Laboratory

References (39)

Show source-provided references
1. 10.1016/j.ccell.2023.02.01610.1016/j.ccell.2023.02.016 ↗
2. 10.1016/j.heliyon.2024.e2748010.1016/j.heliyon.2024.e27480 ↗
3. 10.1038/s41586-023-06256-510.1038/s41586-023-06256-5 ↗
4. 10.1002/adma.20230021610.1002/adma.202300216 ↗
5. 10.1016/j.nantod.2023.10176610.1016/j.nantod.2023.101766 ↗
6. 10.1002/ctm2.28810.1002/ctm2.288 ↗
7. 10.1002/adma.20200205410.1002/adma.202002054 ↗
8. 10.1021/jacs.2c1321810.1021/jacs.2c13218 ↗
9. 10.1016/j.actbio.2023.02.00610.1016/j.actbio.2023.02.006 ↗
10. 10.1016/j.jconrel.2011.11.01310.1016/j.jconrel.2011.11.013 ↗
11. 10.1021/acsnano.5b0707510.1021/acsnano.5b07075 ↗
12. 10.1002/smll.20230908610.1002/smll.202309086 ↗
13. 10.1002/EXP.2022011510.1002/EXP.20220115 ↗
14. 10.26599/NBE.2024.929006010.26599/NBE.2024.9290060 ↗
15. 10.1016/j.jconrel.2023.06.00410.1016/j.jconrel.2023.06.004 ↗
16. 10.1002/adfm.20221140210.1002/adfm.202211402 ↗
17. 10.1002/anie.20201322810.1002/anie.202013228 ↗
18. 10.1002/adfm.20210897110.1002/adfm.202108971 ↗
19. 10.1021/acs.analchem.9b0105310.1021/acs.analchem.9b01053 ↗
20. 10.1021/acs.biomac.8b0023910.1021/acs.biomac.8b00239 ↗
21. 10.1021/acs.nanolett.8b0356810.1021/acs.nanolett.8b03568 ↗
22. 10.1021/acsnano.2c1103710.1021/acsnano.2c11037 ↗
23. 10.1021/acs.nanolett.1c0207310.1021/acs.nanolett.1c02073 ↗
24. 10.1002/JLB.3RU1018-378RR10.1002/JLB.3RU1018-378RR ↗
25. 10.1007/s00011-018-1172-510.1007/s00011-018-1172-5 ↗
26. 10.1038/s41467-023-41592-010.1038/s41467-023-41592-0 ↗
27. 10.1016/j.jconrel.2021.11.04710.1016/j.jconrel.2021.11.047 ↗
28. 10.1152/physrev.00011.200510.1152/physrev.00011.2005 ↗
29. 10.1038/s41590-023-01430-310.1038/s41590-023-01430-3 ↗
30. 10.7150/thno.5092810.7150/thno.50928 ↗
31. 10.1016/j.carbpol.2021.11824510.1016/j.carbpol.2021.118245 ↗
32. 10.2147/IJN.S46631510.2147/IJN.S466315 ↗
33. 10.1016/j.ijpharm.2019.01.04810.1016/j.ijpharm.2019.01.048 ↗
34. 10.1021/acsnano.1c0789310.1021/acsnano.1c07893 ↗
35. 10.1002/adma.20250033710.1002/adma.202500337 ↗
36. 10.1016/j.bioactmat.2023.10.00310.1016/j.bioactmat.2023.10.003 ↗
37. 10.1021/acsami.8b0938810.1021/acsami.8b09388 ↗
38. 10.1002/smll.20220612410.1002/smll.202206124 ↗
39. 10.3390/cells1012344410.3390/cells10123444 ↗